Development of a national prospective study of Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 10, Issue SUPPL. 1, 1996, Pages 38-44

  Mayeux, Richard ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Alzheimer disease; Apolipoprotein E; Prospective study; Risk factors

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; DEMOGRAPHY; DISEASE COURSE; ENVIRONMENTAL FACTOR; ETHNIC GROUP; GENOTYPE; HEREDITY; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SOCIAL ASPECT; TREATMENT PLANNING;

EID: 0029791755     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601031-00011     Document Type: Review

References (38)

1. Ashall F, Goate AM. Role of the beta-amyloid precursor protein in Alzheimer disease. Trends Biochem Sci 1994;19:42-6.
2. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A. Epidemiology of Alzheimer disease. Am J Epidemiol 1992;14:59-82.
3. Brietner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
4. Brogaonkar DS, Schmidit LC, Martin SE, et al. Linkage of late-onset Alzheimer's disease with apolipoprotein-type 4 on chromosome 19. Lancet 1993;342:625.
5. Canadian Study of Health and Aging. Canadian Study of Health and Aging: risk factors for Alzheimer disease in Canada. Neurology 1994;44:2073-80.
6. Corder EH, Saunders AM, Risch NJ, et al. Apolipoprotein type 2 allele decreases the risk for late onset Alzheimer's disease. Nature Genet 1994;7:180-4.
7. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein-type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
9. Devanand D, Sano M, Tang M-X, et al. Depressed mood and the incidence of Alzheimer's disease in the community elderly. Arch Gen Psychiatry 1996;53:175-82.
10. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993;71:160-5.
11. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein genotypes and Alzheimer's disease in a community study of elderly African-Americans. Ann Neurol 1995;37:118-20.
12. Jorm AF, van Duijn CM, Chandra V, et al. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S43-7.
13. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein phenotypes with late onset Alzheimer's disease: population based study. Br Med J 1994;309:636-8.
14. Levy-Lahad E, Wasco W, Poorkal P, et al. Candidate gene for the chromosome 1 familial Alzheimer disease locus. Science 1995;269:973-7.
15. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer disease locus on chromosome 1. Science 1995;269:970-3.
16. Mackisack M, Dobson AJ, Heathcote CR. Predicting the prevalence of a disease in a cohort at risk. Stat Med 1992;11:295-305.
17. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-9.
18. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 1995;45:555-7.
19. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34;752-4.
20. Mietteinen OS. Theoretical epidemiology. Albany: Delmar, 1985.
21. Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E ∈4 and Alzheimer disease in elderly Nigerians. Ann Neurol 1995;38:463-5.
22. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 1990;7:177-85.
23. Paganini-Hill A, Hendersen V. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
24. Payami H, Kaye J, Heston LL, et al. Apolipoprotein genotype and Alzheimer's disease. Lancet 1993;342:738.
25. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-50.
26. Poirier J. Apolipoprotein in animal models of CNS injury and in Alzheimer's disease. Trends Neurol Sci 1994;12:525-30.
27. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
28. Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet 1992;51:1311-24.
29. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994;343:1564-5.
30. Saunders AM, Strittmatter WJ, Pericak-Vance MA, et al. Apolipoprotein-∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-1.
31. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele-∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
32. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
33. Stern Y, Gurland B, Tatemichi TK, Tang M-X, Wilder D, Mayeux R. Influence of education and occupation on the incidence of dementia. JAMA 1994;271:1004-10.
34. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein: high affinity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-81.
35. U.S. Department of Health and Human Services, Public Health Service. Healthy people 2000. DHHS publication no. (PHS) 91-50213, 1990:125.
36. van Duijn CM, Clayton DG, Chandra V, et al. Interaction between genet ic and environmental risk factors for Alzheimer disease: reanalysis of case-control studies. Genet Epidemiol 1994;11:539-51.
37. Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 1994;5:110-6.
38. Wilson PWF, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemia and coronary heart disease. JAMA 1994;272:1666-71.